Navigation Links
IC Sciences Announces Launch of ICS Advisory Services Intellectual Property Platforms Available Through ICSciences Alliance
Date:5/8/2008

BOSTON, May 8 /PRNewswire/ -- Informed Clinical Sciences (ICS) Advisory Services Corporation announced today the launch of the company's three-part Intellectual Property (IP) platform. This Platform suite offers content and instruments through a Medical Informatics Review, an Alliance Business Review, and a Health IT Review, each respectively focused on the sciences, business concerns, and enabling technologies underlying the growth of the informatics and e-health landscapes. The platform's offerings will establish strategic thought leadership and thereby shape thinking in the e-health community. These offerings will define the development and distribution of digital informatics instruments (DIIs) by presenting new frameworks for integrating informatics sciences, business models, and trends, and enabling technologies in the emergent e-health landscape. DIIs are built upon the Internet and related technologies and are used by patients, consumers, or clinicians to capture, exchange, analyze, and present healthcare information so that care is informed by experience, evidence, prediction, and preference. Bringing science, business, and technology to bear will drive the strategic direction and tactical realization of improved care delivery.

With a core aim of fueling research, development, and adoption strategies and efforts, the ICS Advisory Services Corporation IP platform will be offered to both e-health and diverse healthcare industry participants, and present thinking and evidence regarding how DIIs can solve many of the challenges currently facing the healthcare delivery system. It will combine strategic market analysis, technical and business briefs with key action item "takeaways," case studies, scientific analysis tools, and documented best practices and perspectives on implementing "Best in Context"(TM) solutions care delivery. Professional services in the form of commissioned research or strategy and assessment in any of these three areas of core competency will also be available and will enrich the IP offerings.

Anne Marie Biernacki, Executive Vice President, Technology Intelligence Advisor and Director, ICS Advisory Services Corporation Therapeutics Sector, said, "Over the past two years, IC Sciences has been developing the content and finding the knowledge and expertise to deliver via these platforms. We believe that this three-pronged approach of science plus business plus technology is what the field needs to assemble the right combination of offerings to serve diverse and growing needs in the professional, consumer, and therapeutics market sectors."

The IP offerings available to Alliance members, who currently include Revolution Health, Blue Cross Blue Shield of Massachusetts, AthenaHealth, patientslikeme, and others, will be used by clinicians, patients, consumers, payers, and therapeutics manufacturers in myriad strategic and tactical contexts and applications, including patient engagement, collective intelligence among clinician or patient peers, clinical performance management, and therapeutic product support. To learn more about the ICS Advisory Services Intellectual Property offerings available through the ICS Alliance and membership benefits of the Alliance, visit http://www.icsciencesalliance.com. About IC Sciences Corporation IC Sciences Corporation is a closely held, private organization pioneering in the medical information sciences and informed clinical technology markets. The company's core business involves designing, developing, delivering, and advancing a series of informatics instrument classes, including care delivery, cognitive profiling, collective intelligence, therapeutic support, and performance evaluation. For more information, please visit: http://www.ICSciences.com.

About Informed Clinical Sciences Advisory Services Corporation

The ICS Advisory Services Corporation provides consultative engagements and knowledge services related to strategy, design, development, and implementation of digital informatics instruments. ICS Advisory Services' professionals bring expertise from a variety of healthcare and informatics science, technology and business domains to clients from the medical practice, provider institution, professional society, e-health, health payer, medical device, and pharmaceutical market sectors.

Contact:

IC Sciences Corporation

One Joy Street

Boston, MA 02108

publicrelations@icsciences.com

1-800-603-1420


'/>"/>
SOURCE Informed Clinical Sciences Advisory Services Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Advanced Life Sciences Announces First Quarter 2008 Financial Results
2. Battelle Collaborating With Korean Partners to Advance Energy Efficiency and Health and Life Sciences Initiatives in Korea
3. Kosan Biosciences to Present at the Leerink Swann Solid Tumors Roundtable Conference
4. Caliper Life Sciences to Present at Deutsche Banks 33rd Annual Health Care Conference
5. Human Genome Sciences Announces First Quarter 2008 Financial Results and Key Developments
6. Caliper Life Sciences and DiscoveRx Collaborate to Offer Solutions for Cell-Based GPCR Profiling and Lead Optimization
7. YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR AEROLEF(TM) AT AMERICAN PAIN SOCIETY ANNUAL MEETING
8. Skin & Aging Article Finds Derma Sciences MEDIHONEY(TM) Helps to Promote Healing Where Antibiotics Fail
9. Advanced Life Sciences to Host 2008 First Quarter Financial Results Conference Call and Webcast
10. Edwards Lifesciences to Webcast Annual Stockholders Meeting
11. Pressure BioSciences, Inc. to Discuss First Quarter 2008 Financial Results and Provide Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017 DarioHealth Corp. (NASDAQ: ... health and big data solutions, today announced that it ... coverage option for U.S. consumers who want to have ... DarioHealth has signed strategic alliance agreements with partners across ... coverage benefits, and if approved, will supply and bill ...
(Date:3/24/2017)... DUBLIN , Mar. 24, 2017 Research ... Stem Cell (hESC) Research - Global Strategic Business Report" report ... ... Cell (hESC) Research in US$ Million. Annual estimates and forecasts are ... are derived from primary and secondary research. The ...
(Date:3/24/2017)... Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company ... vaccines, today announced participation at the following conferences: ... and Maidstone Life Sciences conference "Cancer Immunotherapy Conference" at ... New York, NY . Agenus will participate in ... am: Robert B. Stein , M.D., Ph.D., President, ...
(Date:3/23/2017)... March 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) ... immune therapies for solid tumor cancers, today announced ... financing it announced last Friday, March 17, 2017. ... institutional investors securities totaling 28,843,692 shares, comprised of ... 10,000,000 shares of Class C Warrants pre-funded at ...
Breaking Biology Technology:
(Date:3/6/2017)... March 6, 2017 Mintigo , ... today announced Predictive Sales Coach TM , its ... sales intelligence into Salesforce. This unique AI application ... sales organizations with deep knowledge of their customers ... intelligent engagement. Predictive Sales Coach extends Mintigo,s existing ...
(Date:3/2/2017)... -- Summary This report provides all the ... its partnering interests and activities since 2010. Download ... Partnering Deals and Alliance since 2010 report provides an ... the world,s leading life sciences companies. On ... inclusion of the most up to date deal and ...
(Date:3/2/2017)... Australia , March 2, 2017 Australian ... Ltd (ASX: CYP), has signed an agreement with ... from the Monash Biomedicine Discovery Institute and Department of ... to conduct a further preclinical study to support the ... treatment of asthma.  Asthma is a ...
Breaking Biology News(10 mins):